UNIVERSITY OF CALIFORNIA, IRVI
843 Health Sciences Drive
November 01, 1994
Hormonal therapy for prostate cancer designedto reduce testosterone levels has been employed for decades andprovides objective remission rates of 40% to 60% and subjectiveresponse rates of 60% to 85%. Orchiectomy, as